2025-04-01 2026-03-31 false No description of principal activity Capium Accounts Production 1.1 09044629 2025-04-01 2026-03-31 09044629 bus:AbridgedAccounts 2025-04-01 2026-03-31 09044629 bus:FRS102 2025-04-01 2026-03-31 09044629 bus:AuditExempt-NoAccountantsReport 2025-04-01 2026-03-31 09044629 bus:SmallCompaniesRegimeForAccounts 2025-04-01 2026-03-31 09044629 bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 09044629 2025-04-01 2026-03-31 09044629 2026-03-31 09044629 bus:RegisteredOffice 2025-04-01 2026-03-31 09044629 core:WithinOneYear 2026-03-31 09044629 core:AfterOneYear 2026-03-31 09044629 1 2025-04-01 2026-03-31 09044629 bus:Director1 2025-04-01 2026-03-31 09044629 bus:Director1 2026-03-31 09044629 bus:Director1 2024-04-01 2025-03-31 09044629 bus:Director2 2025-04-01 2026-03-31 09044629 bus:Director2 2026-03-31 09044629 bus:Director2 2024-04-01 2025-03-31 09044629 bus:Director3 2025-04-01 2026-03-31 09044629 bus:Director3 2026-03-31 09044629 bus:Director3 2024-04-01 2025-03-31 09044629 2024-04-01 09044629 bus:LeadAgentIfApplicable 2025-04-01 2026-03-31 09044629 2024-04-01 2025-03-31 09044629 2025-03-31 09044629 core:WithinOneYear 2025-03-31 09044629 core:AfterOneYear 2025-03-31 09044629 bus:EntityAccountantsOrAuditors 2024-04-01 2025-03-31 09044629 core:IntangibleAssetsOtherThanGoodwill 2025-04-01 2026-03-31 09044629 core:IntangibleAssetsOtherThanGoodwill 2026-03-31 09044629 core:IntangibleAssetsOtherThanGoodwill 2025-03-31 09044629 core:CostValuation core:Non-currentFinancialInstruments 2026-03-31 09044629 core:CostValuation core:Non-currentFinancialInstruments 2025-03-31 09044629 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2026-03-31 09044629 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2026-03-31 09044629 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-03-31 09044629 core:Non-currentFinancialInstruments 2026-03-31 09044629 core:Non-currentFinancialInstruments 2025-03-31 09044629 core:ShareCapital 2026-03-31 09044629 core:ShareCapital 2025-03-31 09044629 core:SharePremium 2026-03-31 09044629 core:SharePremium 2025-03-31 09044629 core:RetainedEarningsAccumulatedLosses 2026-03-31 09044629 core:RetainedEarningsAccumulatedLosses 2025-03-31 09044629 dpl:Item1 2025-04-01 09044629 dpl:Item1 2026-03-31 09044629 dpl:Item1 2024-04-01 09044629 dpl:Item1 2025-03-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 09044629
England and Wales

 

 

 

ARIMON LIMITED



Abridged Accounts
 


Period of accounts

Start date: 01 April 2025

End date: 31 March 2026
 

 
Notes

 
2026
£

  2025
£
(as restated)
Fixed assets      
Intangible fixed assets 3 1,459,501    1,380,388 
Investments 4 7,658    7,658 
1,467,159    1,388,046 
Current assets      
Debtors 718,068    474,022 
Cash at bank and in hand 600,563    428,199 
1,318,631    902,221 
Creditors: amount falling due within one year (1,079,433)   (1,375,504)
Net current assets 239,198    (473,283)
 
Total assets less current liabilities 1,706,357    914,763 
Creditors: amount falling due after more than one year (213,668)   (265,468)
Net assets 1,492,689    649,295 
 

Capital and reserves
     
Called up share capital 3,348    2,867 
Share Premium Account 3,685,906    1,868,838 
Profit and loss account (2,196,565)   (1,222,410)
Shareholders' funds 1,492,689    649,295 
 


For the year ended 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006 the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the board of directors on 01 June 2026 and were signed on its behalf by:


-------------------------------
Arindom Basu
Director
1
General Information
ARIMON LIMITED is a private company, limited by shares, registered in England and Wales, registration number 09044629, registration address 84 RICHMOND ROAD, LONDON SW20 0PD, SW20 0PD.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by Section 1A of the standard)
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Government grants
Government grants received are credited to deferred income. Grants towards capital expenditure are released to the income statement over the expected useful life of the assets. Grants received towards revenue expenditure are released to the income statement as the related expenditure is incurred.
Research and development expenditure
Research and development expenditure is charged to the income statement in the period in which it is incurred.
Foreign currencies
Monetary assets and liabilities denominated in foreign currencies are translated into sterling at the rate of exchange ruling at the statement of financial position date. Transactions in foreign currencies are recorded at the rate ruling at the date of the transaction. All foreign exchange differences are included to the income statement.
Intangible assets
Intangible assets (including purchased goodwill and patents) are amortised at rates calculated to write off the assets on a straight line basis over their estimated useful economic lives. Impairment of intangible assets is only reviewed where circumstances indicate that the carrying value of an asset may not be fully recoverable.
Development expenditures
Research and development expenditure is charged to the income statement in the period in which it is incurred. However, where the directors are satisfied as to the technical, commercial and financial viability of individual projects, development expenditure is deferred and amortised over years during which the company is expected to benefit.
Fixed asset investments
Fixed asset investments are stated at cost less provision for any permanent diminution in value.
2.

Average number of employees

Average number of employees during the year was 9 (2025 : 9).
3.

Intangible fixed assets

Cost Research and Development   Total
  £   £
At 01 April 2025 3,447,621    3,447,621 
Additions 765,557    765,557 
Disposals  
At 31 March 2026 4,213,178    4,213,178 
Amortisation
At 01 April 2025 2,067,233    2,067,233 
Charge for year 686,444    686,444 
On disposals  
At 31 March 2026 2,753,677    2,753,677 
Net book values
At 31 March 2026 1,459,501    1,459,501 
At 31 March 2025 1,380,388    1,380,388 


4.

Investments

Cost Other investments other than loans   Total
  £   £
At 01 April 2025 7,658    7,658 
Additions  
Disposals  
At 31 March 2026 7,658    7,658 

2